Providing solutions to customer challenges and shortening development lead times
First written in FY2016. 24 of 32 entries say "Restated". Latest entry: FY2026.
8 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「In addition to the new organizational structure placing the company’s research and development, sales and manufacturing divisions under the same headquarters, the company continues concurrent engineering with the research and development and manufacturing divisions of its Chinese manufacturing subsidiary, with design, manufacturing and sales progressing simultaneously, to shorten development lead times.」
The company continues integrated operations across research and development, sales and manufacturing, as well as concurrent engineering with its Chinese subsidiary. Research and development expenses were ¥570 million and new patent applications totaled 11, but no new completion stage was indicated. - FY2026-H1RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the current interim consolidated accounting period was ¥293 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥293 million for the current interim consolidated accounting period. No new development milestones, such as the start of mass production of new products, were described. - FY2025RestatedAnnual report
「In addition to the new organizational structure placing the company’s research and development, sales and manufacturing divisions under the same headquarters, the company continues concurrent engineering with the research and development and manufacturing divisions of its Chinese manufacturing subsidiary, with design, manufacturing and sales progressing simultaneously, to shorten development lead times.」
The company continues integrated operations across research and development, sales and manufacturing, as well as shortening development lead times through concurrent engineering with its Chinese subsidiary. Research and development expenses were ¥609 million and 12 new patent applications were disclosed, but no new product was shown to have reached the start-of-mass-production stage. - FY2025-H1RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the current interim consolidated accounting period was ¥266 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥266 million for the current interim consolidated accounting period. No new development milestones, such as the start of mass production of new products, were described. - FY2024AdvancedAnnual report
「The company developed a new cylinder-bed flat-seam sewing machine. By devising and improving the shape of the cylinder tip, it adopted a user-friendly design focused on improving seam quality and making the machine itself easier to maintain. Mass production has begun, and the product has received high praise from users.」
The company’s new flat-seam sewing machine reached the start-of-mass-production stage. Research and development expenses were ¥554 million, and it also disclosed 2 new patent applications. - FY2024-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥387 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥387 million for the first three quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥259 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥259 million for the first two quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2024-Q1RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first quarter of the current consolidated fiscal year was ¥114 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥114 million for the first quarter of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2023-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥371 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥371 million for the first three quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2023-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥222 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥222 million for the first two quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2023-Q1RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first quarter of the current consolidated fiscal year was ¥64 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥64 million for the first quarter of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2022AdvancedAnnual report
「The company developed new overlock and safety-stitch sewing machines with upper and lower feed mechanisms, as well as various labor-saving devices. Mass production has begun, and the products have received high praise from users.」
The company advanced new sewing machines and labor-saving devices from research and development through to the start of mass production. Research and development expenses were ¥408 million, and it also disclosed 4 new patent applications and 1 registration. - FY2022-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥185 million.」
The company continued its research and development activities and disclosed research and development expenses for the first two quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2021AdvancedAnnual report
「The company developed new overlock and safety-stitch sewing machines with upper and lower feed mechanisms, as well as various labor-saving devices. Mass production has begun, and the products have received high praise from users.」
In research and development aimed at addressing customer challenges, new sewing machines and labor-saving devices reached the mass-production stage. - FY2021-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥308 million.」
The company continued its research and development activities and disclosed research and development expenses for the first three quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2021-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥184 million.」
The company continued its research and development activities and disclosed research and development expenses for the first two quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2021-Q1RestatedAnnual report
「For industrial sewing machines, the company worked to cultivate new markets with competitively priced strategic models, expand sales of energy-efficient models equipped with small motors, and propose high-function products that contribute to higher productivity. However, customers showed a cautious stance toward capital investment, resulting in net sales of ¥2,683 million, down 28.4% year on year.」
The company continues to propose high-performance products that contribute to developing new markets, expanding sales of energy-saving models and improving productivity. - FY2020AdvancedAnnual report
「The company developed a special fabric-feed mechanism, the first of its kind in the industry, for flatseam sewing machines, enabling both improved sewing quality and reduced reliance on operator skills. Mass production has begun, and the product has received high praise from users.」
The company advanced flat-seam sewing machines, flatseam sewing machines, non-apparel sewing machines and internally developed motors through to the start of mass production or commercialization. Research and development expenses were ¥408 million. - FY2020-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥312 million.」
The company continued its research and development activities and disclosed research and development expenses for the first three quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2020-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥192 million.」
The company continued its research and development activities and disclosed research and development expenses for the first two quarters of the current consolidated fiscal year. No new development milestones, such as the start of mass production of new products, were described. - FY2019AdvancedAnnual report
「Development of a compact direct-drive motor. The company previously used commercially available motors, but by directly connecting an internally developed motor to the body of its overlock sewing machines, it has improved operability and power efficiency. Mass production has begun, and the product has received high praise from users.」
The company advanced new products and technologies, including internally developed motors, through to the start of mass production. Total research and development expenses were ¥424 million, and patent and other applications and registrations were also carried out in Japan and overseas. - FY2019-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥308 million.」
The company discloses the continuation of its research and development activities and the amount for the first three quarters of the current consolidated fiscal year, but does not describe any new progress in providing solutions or shortening development lead times. - FY2019-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥191 million.」
The company discloses the continuation of its research and development activities and the amount for the first two quarters of the current consolidated fiscal year, but does not describe any new progress in providing solutions or shortening development lead times. - FY2019-Q1AdvancedAnnual report
「For industrial sewing machines, we worked to establish and improve the production system for increasing output of strategically priced models in response to market needs, as well as to begin sales of the new product “LaRgo.”」
The company disclosed a specific product rollout with the start of sales of the new LaRgo product. This indicates that research and development and product introduction had advanced to the market-launch stage. - FY2018AdvancedAnnual report
「The company developed sewing machines with vertically feeding mechanisms that address oil contamination by applying its proprietary semi-dry technology not only to the conventional needle-bar and upper-looper mechanisms but also, for the first time in the industry, to the upper-feed mechanism, as well as various auxiliary labor-saving devices that contribute to improving the quality and productivity of sewn products. It has begun mass production and received high praise from users.」
The company disclosed the start of mass production for multiple research and development results, including new sewing machines and labor-saving devices. Total research and development expenses were ¥424 million, and patent and other applications and registrations were also carried out in Japan and overseas. - FY2018-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥319 million.」
The company discloses the continuation of its research and development activities and the amount for the first three quarters of the current consolidated fiscal year, but does not describe any specific new progress in providing solutions or shortening development lead times. - FY2018-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥211 million.」
The company discloses the continuation of its research and development activities and the amount for the first two quarters of the current consolidated fiscal year, but does not describe any specific new progress in providing solutions or shortening development lead times. - FY2018-Q1RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first quarter of the current consolidated fiscal year was ¥107 million.」
The company discloses the continuation of its research and development activities and the amount for the year-to-date period, but does not describe any specific new progress in providing solutions or shortening development lead times. - FY2017-Q3RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first three quarters of the current consolidated fiscal year was ¥266 million.」
The company discloses the continuation of its research and development activities and the amount for the first three quarters, but does not describe any new progress in providing solutions or shortening development lead times. - FY2017-Q2RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first two quarters of the current consolidated fiscal year was ¥181 million.」
The company discloses the continuation of its research and development activities and the amount for the year-to-date period, but does not describe any new progress in providing solutions or shortening development lead times. - FY2017-Q1RestatedAnnual report
「The amount spent on research and development activities by the entire corporate group during the first quarter of the current consolidated fiscal year was ¥95 million.」
The company discloses the continuation of its research and development activities and the amount for the quarter, but does not describe any new progress in providing solutions or shortening development lead times. - FY2016First statedAnnual report
「The company positions the rapid provision of solutions to problems faced by sewing factories as the mission of its research and development activities, assigns specialized staff, and works to shorten the lead time from planning new products to their market launch.」
It also describes an organizational structure that places the sales and research and development divisions under the same headquarters to connect market needs with development.